Damora Therapeutics Inc (DMRA) Price Prediction & Forecast

$29.000

-1.517 (-5.23%)At close

Price Predictions

1-Day Price Prediction

+0.47%

1-Week Prediction

-4.15%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

Open in app to unlock longer-horizon forecasts.

Loading chart…

DMRA Prediction & Forecast by Similar Chart Analysis

Alphio's DMRA stock price prediction model matches the current Damora Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $29.14 (+0.47%). The 1-week path is $27.80 (-4.15%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Damora Therapeutics Inc Stock?

Damora Therapeutics Inc (DMRA) appears to be a good buy right now due to its strong cash position of $532.9 million, which is expected to fund operations through 2029, and a low current price of $29.00 compared to analyst price targets of $35 to $50. The main risk is its negative earnings trend, with a projected EPS of -0.39 reported in the last earnings, indicating ongoing losses.